It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Anticancer drugs often have widespread effects on the cellular proteome. Here, the authors generate a proteome signature library of drug-treated cancer cell lines and develop a software tool to deconvolute drug targets and gain insights into their mechanisms of action.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
2 Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; Pelago Bioscience AB, Solna, Sweden
3 Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden
4 Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; Faculty of Science, Department of Chemistry, Hacettepe University, Ankara, Turkey
5 Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; SciLifeLab, SE-17 177, Stockholm, Sweden
6 Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; SciLifeLab, SE-17 177, Stockholm, Sweden; Department of Pharmacological & Technological Chemistry, Sechenov First Moscow State Medical University, Moscow, Russia